Effects of Acute Probenecid Administration on Histopathological and Functional Outcomes after Spinal Cord Injury in Rats

Spinal cord injury (SCI) triggers an inflammatory response that is partially mediated by the inflammasome and the production of pro-inflammatory cytokines. We have previously shown that pannexin-1 is involved in the activation of the inflammasome, and that probenecid inhibits this caspase-1-mediated...

Full description

Saved in:
Bibliographic Details
Main Authors: Toru Asari, Sunao Tanaka, Damien D. Pearse, Juan Pablo de Rivero Vaccari, Toshitada Sawada, Yasuyuki Ishibashi, Robert W. Keane, W. Dalton Dietrich
Format: Article
Language:English
Published: Mary Ann Liebert 2025-01-01
Series:Neurotrauma Reports
Subjects:
Online Access:https://www.liebertpub.com/doi/10.1089/neur.2025.0044
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849718606140538880
author Toru Asari
Sunao Tanaka
Damien D. Pearse
Juan Pablo de Rivero Vaccari
Toshitada Sawada
Yasuyuki Ishibashi
Robert W. Keane
W. Dalton Dietrich
author_facet Toru Asari
Sunao Tanaka
Damien D. Pearse
Juan Pablo de Rivero Vaccari
Toshitada Sawada
Yasuyuki Ishibashi
Robert W. Keane
W. Dalton Dietrich
author_sort Toru Asari
collection DOAJ
description Spinal cord injury (SCI) triggers an inflammatory response that is partially mediated by the inflammasome and the production of pro-inflammatory cytokines. We have previously shown that pannexin-1 is involved in the activation of the inflammasome, and that probenecid inhibits this caspase-1-mediated inflammatory process. In this study, we employed an in vivo model of contusive SCI to investigate the therapeutic effect of acute probenecid administration on histopathological and functional outcomes following SCI. Adult female Fischer rats (n = 46) underwent moderate thoracic SCI produced by dropping a 10 g weight from a height of 12.5 mm onto the exposed cord at T9, assigned three different groups, PBS administration group, and 1, 10, 100 mg/kg probenecid group, those were injected subcutaneously 15 min and 12 h after SCI. The sham group (n = 11) was the group that only had a laminectomy and did not have SCI. Histopathological analysis by Luxol Fast Blue/hematoxylin and eosin staining revealed that the penumbra volume was significantly reduced in the probenecid 100 mg/kg group compared with the PBS group. CatWalk gait analysis was performed at 7 weeks after SCI, which showed significant differences in coordination between the PBS and the probenecid 100 mg/kg-treated groups. Acute administration of probenecid after SCI resulted in the preservation of penumbra formation and coordination function in a thoracic SCI rat model. This report suggests that probenecid, an inhibitor of pannexin-1, has the potential to prevent secondary injury after SCI and improve outcomes following SCI.
format Article
id doaj-art-16a0dcaa3f634a8f91a15b0bbf0c6ca7
institution DOAJ
issn 2689-288X
language English
publishDate 2025-01-01
publisher Mary Ann Liebert
record_format Article
series Neurotrauma Reports
spelling doaj-art-16a0dcaa3f634a8f91a15b0bbf0c6ca72025-08-20T03:12:20ZengMary Ann LiebertNeurotrauma Reports2689-288X2025-01-016142543410.1089/neur.2025.0044Effects of Acute Probenecid Administration on Histopathological and Functional Outcomes after Spinal Cord Injury in RatsToru Asari0Sunao Tanaka1Damien D. Pearse2Juan Pablo de Rivero Vaccari3Toshitada Sawada4Yasuyuki Ishibashi5Robert W. Keane6W. Dalton Dietrich7Department of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida, USA.Department of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida, USA.Department of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida, USA.Department of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida, USA.Department of Orthopaedic Surgery, Takaoka Seishikai Hospital, Takaoka, Japan.Department of Orthopaedic Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.Department of Orthopaedic Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.Department of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida, USA.Spinal cord injury (SCI) triggers an inflammatory response that is partially mediated by the inflammasome and the production of pro-inflammatory cytokines. We have previously shown that pannexin-1 is involved in the activation of the inflammasome, and that probenecid inhibits this caspase-1-mediated inflammatory process. In this study, we employed an in vivo model of contusive SCI to investigate the therapeutic effect of acute probenecid administration on histopathological and functional outcomes following SCI. Adult female Fischer rats (n = 46) underwent moderate thoracic SCI produced by dropping a 10 g weight from a height of 12.5 mm onto the exposed cord at T9, assigned three different groups, PBS administration group, and 1, 10, 100 mg/kg probenecid group, those were injected subcutaneously 15 min and 12 h after SCI. The sham group (n = 11) was the group that only had a laminectomy and did not have SCI. Histopathological analysis by Luxol Fast Blue/hematoxylin and eosin staining revealed that the penumbra volume was significantly reduced in the probenecid 100 mg/kg group compared with the PBS group. CatWalk gait analysis was performed at 7 weeks after SCI, which showed significant differences in coordination between the PBS and the probenecid 100 mg/kg-treated groups. Acute administration of probenecid after SCI resulted in the preservation of penumbra formation and coordination function in a thoracic SCI rat model. This report suggests that probenecid, an inhibitor of pannexin-1, has the potential to prevent secondary injury after SCI and improve outcomes following SCI.https://www.liebertpub.com/doi/10.1089/neur.2025.0044inflammasomeprobenecidPannexin-1spinal cord injury
spellingShingle Toru Asari
Sunao Tanaka
Damien D. Pearse
Juan Pablo de Rivero Vaccari
Toshitada Sawada
Yasuyuki Ishibashi
Robert W. Keane
W. Dalton Dietrich
Effects of Acute Probenecid Administration on Histopathological and Functional Outcomes after Spinal Cord Injury in Rats
Neurotrauma Reports
inflammasome
probenecid
Pannexin-1
spinal cord injury
title Effects of Acute Probenecid Administration on Histopathological and Functional Outcomes after Spinal Cord Injury in Rats
title_full Effects of Acute Probenecid Administration on Histopathological and Functional Outcomes after Spinal Cord Injury in Rats
title_fullStr Effects of Acute Probenecid Administration on Histopathological and Functional Outcomes after Spinal Cord Injury in Rats
title_full_unstemmed Effects of Acute Probenecid Administration on Histopathological and Functional Outcomes after Spinal Cord Injury in Rats
title_short Effects of Acute Probenecid Administration on Histopathological and Functional Outcomes after Spinal Cord Injury in Rats
title_sort effects of acute probenecid administration on histopathological and functional outcomes after spinal cord injury in rats
topic inflammasome
probenecid
Pannexin-1
spinal cord injury
url https://www.liebertpub.com/doi/10.1089/neur.2025.0044
work_keys_str_mv AT toruasari effectsofacuteprobenecidadministrationonhistopathologicalandfunctionaloutcomesafterspinalcordinjuryinrats
AT sunaotanaka effectsofacuteprobenecidadministrationonhistopathologicalandfunctionaloutcomesafterspinalcordinjuryinrats
AT damiendpearse effectsofacuteprobenecidadministrationonhistopathologicalandfunctionaloutcomesafterspinalcordinjuryinrats
AT juanpabloderiverovaccari effectsofacuteprobenecidadministrationonhistopathologicalandfunctionaloutcomesafterspinalcordinjuryinrats
AT toshitadasawada effectsofacuteprobenecidadministrationonhistopathologicalandfunctionaloutcomesafterspinalcordinjuryinrats
AT yasuyukiishibashi effectsofacuteprobenecidadministrationonhistopathologicalandfunctionaloutcomesafterspinalcordinjuryinrats
AT robertwkeane effectsofacuteprobenecidadministrationonhistopathologicalandfunctionaloutcomesafterspinalcordinjuryinrats
AT wdaltondietrich effectsofacuteprobenecidadministrationonhistopathologicalandfunctionaloutcomesafterspinalcordinjuryinrats